1. Home
  2. UPLD vs LEXX Comparison

UPLD vs LEXX Comparison

Compare UPLD & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

N/A

Current Price

$3.75

Market Cap

12.2M

Sector

Technology

ML Signal

N/A

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

N/A

Current Price

$3.21

Market Cap

8.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UPLD
LEXX
Founded
2010
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2M
8.7M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
UPLD
LEXX
Price
$3.75
$3.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.75
$1.50
AVG Volume (30 Days)
25.1K
99.9K
Earning Date
05-01-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
N/A
EPS
N/A
N/A
Revenue
$74,767,000.00
$705,923.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.95
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
6.95
52.05
52 Week Low
$0.50
$0.35
52 Week High
$6.65
$14.37

Technical Indicators

Market Signals
Indicator
UPLD
LEXX
Relative Strength Index (RSI) 39.00 34.65
Support Level $0.62 $0.57
Resistance Level $5.65 $13.63
Average True Range (ATR) 0.35 1.77
MACD -0.12 -1.34
Stochastic Oscillator 17.36 1.51

Price Performance

Historical Comparison
UPLD
LEXX

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: